Concepedia

Haiqing Dai

HD

Statistics

Publications

10

Citations

470

H-Index

10

Active since

1996

Affiliations

Pfizer (United States)(Current)

University of Minnesota

Ono Pharmaceutical (United States)

Merck Serono (Switzerland)

Merck (Germany)

Haiqing Dai is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug analysis.

ORCID

Top concepts

Publications per year

1996–2021

10

Publications

10

Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance

Wonkyung Byon, P Chan, MA Tortorici et al. · CPT Pharmacometrics & Systems Pharmacology · 2013 · 181 citations · Full text

Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma

Justin Wilkins, Brigitte Brockhaus, Haiqing Dai et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 74 citations · Full text

Distribution of the Novel Antifolate Pemetrexed to the Brain

Haiqing Dai, Ying Chen, William F. Elmquist · Journal of Pharmacology and Experimental Therapeutics · 2005 · 43 citations

Changing Body Weight–Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma

Ana Novaković, Justin Wilkins, Haiqing Dai et al. · Clinical Pharmacology & Therapeutics · 2019 · 43 citations · Full text

Measurement of drug release from microcarriers by microdialysis

Cory J. Hitzman, Timothy S. Wiedmann, Haiqing Dai et al. · Journal of Pharmaceutical Sciences · 2005 · 28 citations

, , +6

1–5 of 10